市場調查報告書
商品編碼
1521230
2024-2032 年按產品類型(傳統注射器、安全注射器)、應用(免疫注射、治療注射)、最終用戶(醫院、診斷實驗室等)和地區分類的一次性注射器市場報告Disposable Syringes Market Report by Product Type (Conventional Syringes, Safety Syringes), Application (Immunization Injections, Therapeutic Injections), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2024-2032 |
IMARC Group年,全球一次性注射器市場規模達151億美元。
一次性注射器廣泛用於透過靜脈或肌肉注射藥物來治療不同的疾病。它們是一種塑膠注射器,專為醫療、獸醫和研發 (R&D) 領域的一次性使用而設計。與傳統注射器相比,它們更便宜,而且沒有任何維護成本。它們有助於維護患者的安全,同時減少交叉污染的機會。
目前,越來越多的人使用一次性注射器來支持各種慢性疾病的診斷和治療,例如心臟病、癌症、中風、呼吸系統疾病、損傷、糖尿病、阿茲海默症、流感和肺炎。這加上全球手術數量的增加,是推動市場的關鍵因素之一。此外,由於無保護的性接觸和接觸受感染的血液,世界各地患有後天免疫缺乏症候群(愛滋病)的患者人數增加。再加上蓬勃發展的醫療保健產業,正在推動市場的成長。除此之外,主要市場參與者正在關注高效的消毒手術,同時避免醫療保健從業者和患者之間的感染,特別是在冠狀病毒疾病(COVID-19)大流行爆發之後。此外,患者中針刺傷發生率的不斷上升也刺激了對一次性注射器的需求。除此之外,自我注射藥物的上升趨勢也為產業投資者提供了利潤豐厚的成長機會。除此之外,一些國家的政府正在採取舉措,鼓勵使用一次性醫療用品,以防止手術室感染的傳播。這些舉措預計將在未來幾年促進市場的成長。
The global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
Disposable syringes are widely utilized for injecting medicines through intravenous or intramuscular ways to treat different diseases. They are plastic syringes designed for one-time use in the medical, veterinary, and research and development (R&D) fields. They are cheaper compared to traditional syringes without any maintenance costs. They assist in maintaining the safety of the patients while reducing the chances of cross-contamination.
At present, there is a rise in the use of disposable syringes to support the diagnosis and treatment of various chronic diseases, such as heart disease, cancer, stroke, respiratory disease, injuries, diabetes, Alzheimer's disease, influenza, and pneumonia. This, along with the growing number of surgeries across the globe, represents one of the key factors driving the market. In addition, there is an increase in the number of patients suffering from acquired immune deficiency syndrome (AIDS) around the world due to unprotected sexual contact and contact with infected blood. This, coupled with the burgeoning healthcare industry, is propelling the growth of the market. Besides this, key market players are focusing on efficient sterilizing surgery while avoiding infections among healthcare practitioners and patients, especially after the outbreak of the coronavirus disease (COVID-19) pandemic. Moreover, the growing incidences of needlestick injuries among patients are catalyzing the demand for disposable syringes. Besides this, the rising trend of self-injecting medicines is offering lucrative growth opportunities to industry investors. Apart from this, governments of several countries are undertaking initiatives to encourage the adoption of disposable medical supplies for preventing the spread of infections in operating rooms. These initiatives are projected to bolster the growth of the market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global disposable syringes market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application, and end user.
Conventional Syringes
Safety Syringes
Retractable Safety Syringes
Non-Retractable Safety Syringes
Immunization Injections
Therapeutic Injections
Hospitals
Diagnostic Laboratories
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, Henke-Sass Wolf GmbH, Nipro Corporation, Novo Nordisk A/S, Retractable Technologies Inc., Terumo Corporation and Vita Needle Company.